2022
DOI: 10.3389/fphar.2022.845591
|View full text |Cite
|
Sign up to set email alerts
|

Berberine: A Promising Treatment for Neurodegenerative Diseases

Abstract: Berberine, as a natural alkaloid compound, is characterized by a diversity of pharmacological effects. In recent years, many researches focused on the role of berberine in central nervous system diseases. Among them, the effect of berberine on neurodegenerative diseases has received widespread attention, for example Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and so on. Recent evidence suggests that berberine inhibits the production of neuroinflammation, oxidative, and endoplasmic reticulum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 116 publications
0
9
0
Order By: Relevance
“…It has been reported to have broad antiviral activities against human immunodeficiency virus, dengue virus, zika virus, human cytomegalovirus, human papilomavirus, hepatitis C virus, chikungunya virus, human influenza virus, respiratory syncytial virus, herpes simplex virus, SARS-CoV-2, and enteroviruses ( Hayashi et al, 2007 ; Mahata et al, 2011 ; Song et al, 2014 ; Shin et al, 2015 ; Warowicka et al, 2020 ; Varghese et al, 2021 ). In addition, BBR has been shown to cross the blood-brain barrier efficiently and exhibited neuroprotective effects in many neurological disorders ( Kulkarni and Dhir, 2010 ; Cheng et al, 2022 ). Therefore, BBR may hold promising efficacy for neuronal injury caused by EV71 infection.…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported to have broad antiviral activities against human immunodeficiency virus, dengue virus, zika virus, human cytomegalovirus, human papilomavirus, hepatitis C virus, chikungunya virus, human influenza virus, respiratory syncytial virus, herpes simplex virus, SARS-CoV-2, and enteroviruses ( Hayashi et al, 2007 ; Mahata et al, 2011 ; Song et al, 2014 ; Shin et al, 2015 ; Warowicka et al, 2020 ; Varghese et al, 2021 ). In addition, BBR has been shown to cross the blood-brain barrier efficiently and exhibited neuroprotective effects in many neurological disorders ( Kulkarni and Dhir, 2010 ; Cheng et al, 2022 ). Therefore, BBR may hold promising efficacy for neuronal injury caused by EV71 infection.…”
Section: Introductionmentioning
confidence: 99%
“…Jiang et al reported that berberine is a safe and effective drug in patients with colorectal cancer and is beneficial in the treatment of these patients 20 . Similarly, human studies have shown that berberine is an effective agent in neurodegenerative disorders such as the Parkinson’s and Alzheimer’s diseases due to its potent antioxidant effect 21 . As oxidative stress is one of the most important steps in the underlying mechanism of NIHL, we predict that berberine can also be used for NIHL in humans with its strong antioxidant activity.…”
Section: Discussionmentioning
confidence: 99%
“…Berberine's small size allows it to effectively cross the blood-brain barrier, acting on a number of molecular targets. Many scholars [77][78][79] have found that berberine has broad potential in the treatment of neurodegenerative diseases. However, its benefits have only been discovered in recent years, so only a few studies have been performed on the subject.…”
Section: Coptidis Rhizomamentioning
confidence: 99%